Bone Marrow Transplant Survival More Than Doubles For Young High-Risk Leukemia Patients
7/15/2011
St. Jude Children's Research Hospital investigators reported markedly improved survival of pediatric patients transplanted for high-risk leukemia regardless of donor; cite treatment advances and better donor selection. Bone marrow transplant survival more than doubled in recent years for young, high-risk leukemia patients treated at St...
Therapy Adds Life, Lessens Pain In Brain Cancer Patients
7/15/2011
Approximately five to ten percent of patients with primary or metastatic cancer suffer from devastating neurological complications such as headaches, seizures, confusion, difficulty swallowing and visual disturbances. These deficits are caused by a life-threatening form of brain invasion from cancer called neoplastic meningitis...
Girls On Top At Google Science Fair
7/14/2011
The three top winners at this year's Google Science Fair were all girls: Shree Bose, a high-school student from Fort Worth, Texas was the Grand Prize winner (and also winner in the 17-18 age group), with Naomi Shah from Portland, Oregon (15-16 age group) and Lauren Hodge from York, Pennsylvania (13-14) winning in the other two categories...
Stem Cells Restore Cognitive Abilities Impaired By Brain Cancer Treatment
7/14/2011
Human neural stem cells are capable of helping people regain learning and memory abilities lost due to radiation treatment for brain tumors, a UC Irvine study suggests. Research with rats found that stem cells transplanted two days after cranial irradiation restored cognitive function, as measured in one- and four-month assessments...
YERVOY™ (Ipilimumab) Approved For The Treatment Of Previously-Treated Advanced Melanoma In The EU
7/14/2011
Bristol-Myers Squibb today announced that the European Commission has approved YERVOY™ (ipilimumab) for the treatment of adult patients with previously-treated advanced melanoma...
Cancer Studies Less Likely Than Other Research Fields To Make Data Available For Reuse
7/14/2011
A new study finds that -- even in a field with clear standards and online databases -- the rate of public data archiving in cancer research is increasing only slowly. Furthermore, research studies in cancer and human subjects are less likely than other research studies to make their datasets available for reuse...
Growth Of Neuroblastoma Cancer Cells Inhibited By Progesterone
7/14/2011
High doses of the hormone progesterone can kill neuroblastoma cells while leaving healthy cells unscathed, scientists at Emory University School of Medicine have found in laboratory research. The results, published in the journal Molecular Medicine, suggest that progesterone could be used to fight neuroblastoma, the most common form of cancer affecting small children...
Improving Surgical Outcomes For Children, Cancer Patients At UT
7/14/2011
Faculty and students at the Cockrell School of Engineering at The University of Texas at Austin are developing ways for cancer patients and children born with facial deformities to make more informed decisions about which reconstructive surgeries would be most aesthetically pleasing and practical based on their individual body types and personal preferences...
Single Drug And Soft Environment Can Increase Platelet Production
7/14/2011
Humans produce billions of clot-forming platelets every day, but there are times when there aren't enough of them, such as with certain diseases or during invasive surgery. Now, University of Pennsylvania researchers have demonstrated that a single drug can induce bone marrow cells called megakaryocytes to quadruple the number of platelets they produce...
Why Men Are At Higher Risk For Stomach Cancer
7/14/2011
MIT researchers show how estrogen protects women from the gastric inflammation that can lead to cancer. Several types of cancer, including stomach, liver and colon, are far more common in men than in women...